First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study

First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study

Introduction: Breast cancer (BC) is the commonest cancer among females worldwide. Some patients present initially at advanced stages and more than 50% of them will develop metastasis (MBC) at some point. Compared to single agents, combination chemotherapy produces higher response rates (RR), longer...

Full description

Bibliographic Details
Main Authors: Mostafa M. Elserafi, Ahmed A. Zeeneldin, Ibrahim M. Abdelsalam, Hanan R. Nassar, Manar M. Moneer, Wafa H. Buhoush
Format: Article
Language:English
Published: SpringerOpen 2018-03-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Metastatic breast cancer
Chemotherapy
Combination
Sequential
Paclitaxel
Cisplatin
Online Access:http://www.sciencedirect.com/science/article/pii/S1110036218300025

Internet

http://www.sciencedirect.com/science/article/pii/S1110036218300025

Similar Items